100%(1)100% нашли этот документ полезным (1 голос)
5K просмотров117 страниц
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection.
( 12) Pa tent Applica tion Publica tion ( 10) Pub. N o. : US 2012/0251502 A1 Towner et a l. ( 4 3 ) Pub. D a te: Oct. 4 , 2012 ( 54 ) HUMAN EBOLA VIRUS SPECIES AN D Publica tion Cla s s i? ca tion COMPOSITION S AN D METHOD S THEREOF ( 51) Int. Cl. ( 7 5) Inv entors : J ona th a n S. ToW ner, Atla nta , GA A61K 3 5/7 6 ( 200601) ( US) ; Stua rt T. N ich ol, Atla nta , GA C07 H 21/04 ( 200601) ( US) ; J a mes A. Comer, Atla nta , CIZN 7 /04 ( 200601) GA ( US) ; Th oma s G. Ks ia z ek , C07 K 14 /08 ( 200601) Atla nta , GA ( US) ; Pierre E. Rollin, A61K 3 8 /02 ( 2006- 01) Atla nta , GA ( Us ) A61K 3 1/7 08 8 ( 2006. 01) C07 K 7 /06 ( 2006. 01) ( 7 3 ) As s ig nee: Th e Gov ernment of th e US a s C07 K 7 /08 ( 200601) Repres ented by th e Secreta ry of CIZN 7 /00 ( 200601) th e D ept. of h ea lth , Atla nta , GA C07 H 21/02 ( 200601) ( Us ) ( 52) U. S. Cl. . . . . . . . . . . . . . . . . . . 4 24 /9 3 . 6; 4 3 5/23 5. 1; 53 6/23 7 2; ( 21) App1_ N O; 13 /125, 3 9 0 4 3 5/23 6; 53 0/3 50; 514 /1. 1; 514 /4 4 R; 53 0/3 3 0; 53 0/3 29 ; 53 0/3 28 ; 53 0/3 27 ; 53 0/3 26; 53 0/3 25; ( 22) PCT Filed: Oct. 26, 2009 53 0/3 24 ( 8 6) PCT N o. : PCT/US09 /6207 9 ( 57 ) ABSTRACT 3 7 1 ( c) ( 1) , Com . . . . pos itions a nd meth ods including a nd rela ted to th e Ebola ( 2) ( 4 ) D a te: J un 21 2011 Bundibug y o v irus ( EboBun) a re prov ided. Compos itions a re Rela ted U 5 Applica tion D a ta prov ided th a t a re opera ble a s immunog ens to elicit a nd ' ' immune res pons e or protection f rom EboBun ch a lleng e in a ( 62) D iv is ion of a pplica tion N o, 61 /108 , 17 5, ? led on Oct s ubj ect s uch a s a prima te. Inv entiv e meth ods a re directed to 24 , 2008 . detection a nd trea tment of EboBun inf ection. Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 1 0f 27 US 2012/0251502 A1 09 D FIC 19 9 9 1/100 Ra v n Keny a 19 8 7 M a l' bu F9 _ 9 4 Oz olin Zimba bwe 19 7 5 07 BBC 19 9 9 05 D RC 19 9 9 13 7 9 0 Ang ola 2005 Popp Ug a nda /Germa ny 19 67 Mus ok e Keny a 19 8 0 1mm Za |re, Ya mbuk u 19 7 6 & Za Ire, Kik wit19 9 5 1/100 Cote d lv 0ire19 9 4 Ebola 1 T 1/100 |: S|, lda l |, Gulu Ug a nda 2000 0. 5 s ubs t/s ite Hes ton USA 19 8 9 Fig . 1 Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 2 0f 27 US 2012/0251502 A1 N . Ubm po. p0. p0. p0. p0. P0. p0. p0. 3 0a m 3 2E 3 2E 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 2E 3 2E 3 2E Eda m 3 2E 3 0a m 3 0a m 3 3 m . 3 25 3 2E 3 2E 3 0a m 3 2E 3 2E 3 2E Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 4 0f 27 US 2012/0251502 A1 500a 04 5054 004 54 5008 4 3 9 20054 0508 09 4 050058 8 58 8 500504 58 4 0554 8 04 0005028 4 04 4 0: w? uua ? umwmwwa ? 21054 59 6025208 uumwa a wa 2054 22000560504 0504 0. ua a mwmug uua mwa dwumwmmuwm 4 4 4 8 9 4 554 08 19 5a mma mma da wwwa wwa mwug oua mwoa mma mma wa mwwo009 4 4 04 0254 8 4 8 oa odwdummuoa mwodwa mwog m i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . . . . . . . . . . . . . . . . . . . . . i . . . . . . . . i . . . . i . . . . 8 2 3 2 Om? 3 2 8 2 0mg 3 3 0mg 3 3 3 3 h o. h o. h o. h o. 3 0a m 3 0a m 3 0a m 3 . 3 m 3 0mm 3 0mm 3 0mm 3 0mm 2. 0mm 3 6a m 3 2E 3 2E 3 2E 2. 0mm 3 0a m 3 0a m 3 0mm 3 . 25 3 0mm 3 . 0mm 3 . 0mm Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 6 0f 27 US 2012/0251502 A1 . . i . . . . i . . . . i . . . . . . . . i . . . . i . . . . i . . . . . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . comm ommw ommm opmm ommm ommm owmm ommm ommm ommm i . . . . i . . . . i . . . . i . . . . . . . . i . . . . i . . . . i . . . . . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . i . . . . 00mm 03 m 8 % 9 5m 3 % 9 3 m 03 m 3 3 ON ? ola m p0. po. p0. p0. po. p0. p0. 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 . 25 3 . 25 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 . 25 3 . 0mm 3 6a m 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 7 0f 27 US 2012/0251502 A1 h o. h o. P0. P0. P0. P0. 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 3 m 3 2E 3 2E 3 0a m 3 0a m 3 0a m 3 0a m mdonm 3 0a m 3 0a m 3 0a m 3 6a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 8 0f 27 US 2012/0251502 A1 00a m ooom omom onom omom omom onom omom owom o? om ooom coon omon a non omon omon onmn omon omon o? on oown ommn ommn ov mn owmn ommn onmn ommn ommn o? mn oomn omnn ownn onnn ownn omnn onnn omnn omnn o? nn h o. h o. h o. h o. h o. h o. h o. 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 6a m 3 2E 3 . 25 3 . 0mm 3 . 0mm 3 . 0mm 3 . 0mm 3 . 0mm 3 . 0mm 3 . 0mm 3 0mm Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 11 0f 27 US 2012/0251502 A1 P0. P0. P0, 3 0mm 3 0a m 3 0mm 3 2E 3 2E 3 2E 12E 3 2E 3 2E 3 0a m 3 2E 3 2E 3 . 0mm 3 . 0mm 5. 2m. 3 2E 3 2E 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 12 0f 27 US 2012/0251502 A1 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 25 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 50a m 50a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 13 0f 27 US 2012/0251502 A1 P0. h o. h o. P0. h o. b0. 3 0a m 3 0a m 3 2E 3 2E 3 2E ma ca w 3 0a m 3 3 m 3 3 m 3 0a m 3 0mm 3 0mm 3 2m. 3 0mm 3 0a m 3 0mm 3 3 m 25 3 3 m 3 3 m 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 15 0f 27 US 2012/0251502 A1 P0. h o. h o, P0, 22E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 0a m 3 2E 3 2E ma nna 3 3 m 25 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 16 0f 27 US 2012/0251502 A1 h o. P0. h o. h o. h o. um _ UH OMUD AMUGD M uh . UHHUN 50a m 50a m 3 0a m 3 0a m 3 0a m 3 0a m 3 6mm 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 0a m 3 2E 3 2E 50a m 50a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 17 0f 27 US 2012/0251502 A1 p0, po, MHOQ H MHOD M MHOQ M MHOD H MHOAM MHOD H MHOD H MHOD M ? HOnnm mdoonm Q HOQ H MHOD M Q HOnnm MHOD H MHOAM Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 18 0f 27 US 2012/0251502 A1 oomN H omwmH owwN H oPwmH owwmH omwmH owwN H omwmH omwmH oliwmH ommHH oPmHH owmmH ommHH owmmH ommHH ommmH ommHH h o. h o. h o. h o. h o. 3 0a m 3 0a m 3 0a m 3 2E 3 2E 3 0a m 3 2E 3 2E 3 2E 3 2E 3 2E 3 2E 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m Pa tent Applica tion Publica tion Oct. 4 , 2012 Sh eet 19 0f 27 US 2012/0251502 A1 h o PO. P0. P0. h oV PoV wh V UHHMN wmV UH Q MUSAMMESM 3 0a m 3 0a m 3 0a m 3 0mm 3 0mm 3 0mm 3 2E 3 0a m 3 0a m 3 0a m 3 0a m 20a m 3 0mm 3 0a m 3 0a m 3 0a m 3 0a m 3 0a m 20a m 3 0a m 3 0a m